{{Rsnum
|rsid=7961824
|Gene=FGF23
|Chromosome=12
|position=4367051
|Orientation=plus
|GMAF=0.2149
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 35.4 | 55.8
| HCB | 4.4 | 29.9 | 65.7
| JPT | 0.9 | 19.5 | 79.6
| YRI | 2.7 | 18.4 | 78.9
| ASW | 0.0 | 19.3 | 80.7
| CHB | 4.4 | 29.9 | 65.7
| CHD | 2.8 | 31.2 | 66.1
| GIH | 5.0 | 36.6 | 58.4
| LWK | 0.9 | 22.7 | 76.4
| MEX | 3.4 | 31.0 | 65.5
| MKK | 0.6 | 16.0 | 83.3
| TSI | 4.9 | 38.2 | 56.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24146310
|Title=Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}